Wujun Chen, Yingchun Shao, Xiaojin Peng, Bing Liang, Jiazhen Xu, Dongming Xing, & Dongming Xing. (2022). Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection. Frontiers Media S.A..
Chicago Style (17th ed.) CitationWujun Chen, Yingchun Shao, Xiaojin Peng, Bing Liang, Jiazhen Xu, Dongming Xing, and Dongming Xing. Review of Preclinical Data of PF-07304814 and Its Active Metabolite Derivatives Against SARS-CoV-2 Infection. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationWujun Chen, et al. Review of Preclinical Data of PF-07304814 and Its Active Metabolite Derivatives Against SARS-CoV-2 Infection. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.